Skip to main content

Table 4 Multivariate analyses of clinical factors affecting one year virologic response

From: Comparison of the long-term efficacy between entecavir and tenofovir in treatment- naïve chronic hepatitis B patients

Factors

RR

95% CI

P

Disease status (CHB/LC)

0.559

0.205–1.521

0.255

IVR-3 (+/−)

6.214

2.500–15.443

<0.001

HBeAg (−/+)

3.184

0.977–10.377

0.055

Serum HBV DNA level (log10 IU/mL)

0.605

0.357–1.023

0.061

  1. RR, relative risk, 95% CI 95% confidence interval, CHB chronic hepatitis B, HBeAg hepatitis B e antigen, HBV hepatitis B virus, IVR-3 initial virologic response at 3 months, LC liver cirrhosis
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us